Many oncologists unaware of cancer clot riskSeptember 10, 2003Patients receiving cancer treatments are at greater risk of blood clots, yet more than a quarter of oncologists do not recognise their clotting effects and preventive measures are rarely used, finds a study in this week’s BMJ. Researchers in Manchester surveyed 106 oncologists in northern England. The most common treatment was chemotherapy, used by 39% of oncologists, 9% used hormone therapy, and 42% used radiotherapy. A total of 29 (27%) thought their patients were not at risk of venous thromboembolism (blockage of a blood vessel by a blood clot) regardless of the type of tumour treated. Seventy-one oncologists believed that hormone therapy posed little or no increased risk to patients, 83 thought the same for chemotherapy and 96 for radiotherapy. Of the 106 respondents, 84 reported not routinely using prophylaxis, such as aspirin or warfarin, in chemotherapy, 79 in hormone therapy, and 86 in radiotherapy. A total of 19 oncologists never used prophylaxis for venous thromboembolism. The good response rate to this questionnaire demonstrates a reliable representation of current practice in the north of England, say the authors. National guidelines on prophylaxis for venous thromboembolism during cancer treatment are needed, they conclude. British Medical Journal (BMJ) |
|||||||||||||||||||||
| Related Chemotherapy Current Events and Chemotherapy News Articles Feedback loop explains inflammatory effect on intestinal lining Signals released by immune cells during a bout of inflammatory bowel disease interfere with intestinal cells' ability to regenerate. Yet people with inflammatory bowel diseases have a significantly higher risk of developing colon cancer: a hyper-activation of growth in those same intestinal cells. Researchers find new chemotherapy combination shows promise in endometrial cancer Researchers from The University of Texas M. D. Anderson Cancer Center report that in a small study of women with advanced or recurrent endometrial cancer, gemcitabine and cisplatin, when used in combination, produced a response rate in fifty percent of patients. Age, gender can affect risk to radiation treatment Doctors have a clearer picture than ever before of how much radiation reaches sensitive tissues during routine X-rays and similar imaging, thanks to sophisticated models of the human body being developed at the University of Florida. Researchers discover brain tumor's 'grow-or-go' switch Cancer cells in rapidly growing brain tumors must adjust to periods of low energy or die. When energy levels are high, tumor cells grow and proliferate. When levels are low, the cells grow less and migrate more. Research findings expected to ease treatment of low neutrophil counts in cancer patients For patients like 10-year-old Sabrina Jo Spence, new research led by St. Jude Children's Research Hospital investigators meant fewer injections to combat the drop in white blood cells following her recent chemotherapy. Fewer platelets could be used for some cancer and bone-marrow transplantation patients Physicians may be able to safely lower the platelet dosage in transfusions for cancer and bone-marrow transplant patients without risking increased bleeding, according to new research involving UT Southwestern Medical Center and 28 other medical institutions. Dietary supplements discouraged for prostate cancer patients Prostate-specific dietary supplements should not be taken during radiation therapy treatments because they have been shown to increase the radiosensitivity of normal prostate cell lines, leading to normal tissue complications, according to a study in the March issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology (ASTRO). Study Shows Potential for Using Algae to Produce Human Therapeutic Proteins Pharmaceutical companies could substantially reduce the expense of costly treatments for cancer and other diseases produced from mammalian or bacterial cells by growing these human therapeutic proteins in algae-rapidly growing aquatic plant cells that have recently gained attention for their ability to produce biofuels. Improvements needed in genomic test result discussions A new study has found that one in three early-stage breast cancer patients who received genomic testing when deciding about treatment options felt they did not fully understand their discussions with physicians about their test results and their risk of recurrence. About one in four experienced distress when receiving their test results. Delaying post-surgical radiation increases risk of breast cancer recurrence in older women Older women who have had breast cancer surgery have a greater risk of the cancer returning if they delay their post-surgical radiation treatment, report Dana-Farber Cancer Institute scientists. More Chemotherapy Current Events and Chemotherapy News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||